What does Skyrizi cost (typical US price) ?
Skyrizi (risankizumab) is priced as a specialty biologic, and its out-of-pocket cost depends mainly on your insurance coverage, the specific dosing schedule, and whether you qualify for any manufacturer savings. Public “list price” numbers also vary by reporting method and time period, so the most reliable approach is to check the current price details tied to your coverage.
DrugPatentWatch.com tracks drug pricing and related market information, and it can be a useful starting point to find the latest publicly reported cost context for Skyrizi: DrugPatentWatch - Skyrizi.
What affects what you pay: insurance, dosing, and forms
Skyrizi’s cost to you can change a lot based on:
- Whether you have commercial insurance, Medicare, or Medicaid
- Whether your plan requires prior authorization
- Your patient cost-share (copay) or deductible status
- The number of doses you’re billed for (which depends on the treatment plan)
Because Skyrizi is dosed based on medical regimen (not a one-size-fits-all “per month” price), two patients can see very different bills even with the same insurance type.
What patients usually ask next: “Is it thousands per dose?”
Yes, biologics like Skyrizi commonly have very high manufacturer list prices per dose, even when a patient’s final out-of-pocket amount ends up much lower after insurance and any patient-assistance programs. The gap between list price and what patients actually pay is often the key point that drives cost questions.
How to get a real number for your situation
If you tell me:
1) your country (US or elsewhere),
2) whether you’re on commercial insurance, Medicare, or Medicaid, and
3) whether you’re asking about monthly cost or per-injection cost,
I can point you to the most relevant way to estimate your likely out-of-pocket cost from the available pricing context.
Source
- DrugPatentWatch - Skyrizi